Completing data — refresh the page later to see the latest
160098-96-4Nc1nc2c(cnn2CCc2ccccc2)c2nc(-c3ccco3)nn12UTLPKQYUXOEJIL-UHFFFAOYSA-NLSM-3822 is a member of triazolopyrimidines.
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P264, P264+P265, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, and P362+P364 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids.
Compounds that selectively bind to and block the activation of ADENOSINE A2 RECEPTORS.
UsesSCH 58261 is a potent and selective A2A adenosine receptor antagonist.
DefinitionChEBI: LSM-3822 is a member of triazolopyrimidines.
160098-96-4DTXSID80166799CHEMBL17127CHEBI:93424